Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Asset Writedowns and Impairment (2023 - 2025)

Historic Asset Writedowns and Impairment for Strata Critical Medical (SRTA) over the last 3 years, with Q3 2025 value amounting to -$385000.0.

  • Strata Critical Medical's Asset Writedowns and Impairment changed N/A to -$385000.0 in Q3 2025 from the same period last year, while for Jun 2025 it was $385000.0, marking a year-over-year decrease of 9854.78%. This contributed to the annual value of $5.8 million for FY2024, which is 7224.98% down from last year.
  • Strata Critical Medical's Asset Writedowns and Impairment amounted to -$385000.0 in Q3 2025.
  • In the past 5 years, Strata Critical Medical's Asset Writedowns and Impairment registered a high of $20.6 million during Q4 2023, and its lowest value of -$385000.0 during Q3 2025.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $171000.0 (2023), whereas its average is $3.8 million.
  • Within the past 5 years, the most significant YoY rise in Strata Critical Medical's Asset Writedowns and Impairment was 322.58% (2025), while the steepest drop was 9380.24% (2025).
  • Over the past 3 years, Strata Critical Medical's Asset Writedowns and Impairment (Quarter) stood at $20.6 million in 2023, then tumbled by 72.17% to $5.7 million in 2024, then crashed by 106.72% to -$385000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at -$385000.0 for Q3 2025, versus $355000.0 for Q2 2025 and $30000.0 for Q1 2025.